ArticleBMJ open respiratory research2026

Bexotegrast for treatment of idiopathic pulmonary fibrosis (BEACON-IPF): study protocol for a multinational, phase 2b/3, double-blind, randomised, multicentre, controlled trial.

Wim A Wuyts et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.